Skip to main content


Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Evaluation of intravenous voriconazole in patients with compromised renal function

  • Craig M Lilly1,
  • Verna L Welch2,
  • Thomas Mayer1,
  • Paul Ranauro1,
  • Joanne Meisner1 and
  • David R Luke2Email author
BMC Infectious Diseases201313:14

DOI: 10.1186/1471-2334-13-14

Received: 24 March 2012

Accepted: 8 January 2013

Published: 16 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting

Original Submission
24 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Apr 2012 Reviewed Reviewer Report - Nikolaos Sipsas
3 Jul 2012 Reviewed Reviewer Report - Dionissios Neofytos
18 Jul 2012 Reviewed Reviewer Report - George Thompson
26 Oct 2012 Author responded Author comments - David Luke
Resubmission - Version 3
26 Oct 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
6 Nov 2012 Reviewed Reviewer Report - Nikolaos Sipsas
Resubmission - Version 5
Submitted Manuscript version 5
8 Jan 2013 Editorially accepted
16 Jan 2013 Article published 10.1186/1471-2334-13-14

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

University of Massachusetts Medical School
Medical Affairs, Pfizer Inc